Clinical Trial Update: A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TO-O-1001 eye drops evaluating IOP-lowering effects in healthy subjects and patients with open-angle glaucoma or ocular hypertension (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TO-O-1001

Snippet

Sponsor: Theratocular Biotek Co. | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: UNKNOWN